humanwell puracap pharmaceuticals (wuhan) co., ltd. (“humanwell puracap”), founded in 2009 at the center of wuhan optics valley – humanwell medical industrial park of wuhan biological industry base, covering an area of 60,253.54 square meters, is jointly established by humanwell healthcare and inspire with an investment of rmb 1 billion.
equipped with most advanced softgel manufacturing and packaging equipment from us, europe, and south korea, it is a world-class softgel pharmaceutical manufacturing base in china. passing through the on-site audit of fda with no defects in 2015 and 2017 respectively, it is the first softgel pharmaceutical manufacturing company approved by fda in hubei province.
humanwell puracap currently has a number of softgel production lines with annual capacity up to 8 billion softgels. being able to provide highly quality softgel r&d, oem service and china-us registration work, it is currently a supplier of major mainstream pharmaceutical retail enterprises in the us, and also cooperates with world-class pharmaceutical enterprises at home and abroad to provide oem and product cooperation, etc.
humanwell puracap is a pharmaceutical enterprise based on the high-end technology platform of the pharmaceutical industry in the world, which requires itself with strict international quality standards. it is a world-class pharmaceutical enterprise that can stand shoulder to shoulder with excellent global pharmaceutical enterprises.